tert-Butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate

Catalog No. :
ACTXFK240
CAS No. :
2173992-48-6
Molecular Formula :
C24H42N4O8
Molecular Weight :
514.62

IUPAC Name:tert-butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate

tert-Butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$60.00Login to see priceIn stockInquiry
5g97%$232.00Login to see priceIn stockInquiry
10g97%$439.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate
IUPAC Nametert-butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate
MDL No.MFCD31620825
Molecular FormulaC24H42N4O8
Molecular Weight514.62
SMILESO=C(O)C(O)=O.O=C(N(CCNC1)C21CC2)OC(C)(C)C.O=C(N(CCNC3)C43CC4)OC(C)(C)C
InChI KeyWKRFVQBWZMOMMH-UHFFFAOYSA-N
Synonym2173992-48-6 | oxalic acid | bis(tert-butyl 4,7-diazaspiro[2.5]octane-4-carboxylate) | tert-Butyl 4,7-diazaspiro[2.5]octane-4-carboxylate hemioxalate | MFCD31620825 | AKOS037644722 | AS-54278 | 4-Boc-4,7-diazaspiro[2.5]octane hemioxalate | P17706 | tert-b
CAS No.2173992-48-6
PubChem CID134129817

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTXFK240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPJSK591 route compound structure diagram
    ACPJSK591674792-03-1 In Stock
  2. Then
  3. ACTXFK240 route product structure diagram
    ACTXFK2402173992-48-6 In Stock
Inquiry

2. ACTXFK240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTXFK240 route product structure diagram
    ACTXFK2402173992-48-6 In Stock
Inquiry

Comments (0)